Evidence map›Paper›PMID 24570173›Full record

ArticleJournal of radiation research2014

Profiling of low molecular weight proteins in plasma from locally irradiated individuals.

Reetta Nylund, Elina Lemola, Sonja Hartwig, Stefan Lehr, Anna Acheva, Jutta Jahns, Guido Hildebrandt, Carita Lindholm

Open access · goldAbstract read
In one paragraph

Article in Journal of radiation research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Ionizing radiation exposure: hazards, prevention, and biomarker screening.Environmental science and pollution research international · 2018
    Article
  5. Article
  6. Article
  7. Radiation takes its Toll.Cancer letters · 2015
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Reetta NylundSTUK - Radiation and Nuclear Safety Authority, Laippatie 4, PO Box 14, 00881 Helsinki, Finland reetta.nylund@stuk.fi.
Elina LemolaSTUK - Radiation and Nuclear Safety Authority, Laippatie 4, PO Box 14, 00881 Helsinki, Finland.
Sonja HartwigInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Auf'm Hennekamp 65, 40225 Düsseldorf, Germany.
Stefan LehrInstitute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Auf'm Hennekamp 65, 40225 Düsseldorf, Germany.
Anna AchevaSTUK - Radiation and Nuclear Safety Authority, Laippatie 4, PO Box 14, 00881 Helsinki, Finland.
Jutta JahnsDepartment of Radiotherapy and Radiation Oncology, University of Leipzig, Stephanstrasse 9a, 04103 Leipzig, Germany.
Guido HildebrandtDepartment of Radiotherapy and Radiation Oncology, University of Leipzig, Stephanstrasse 9a, 04103 Leipzig, Germany Department of Radiotherapy, University of Rostock, Suedring 75, 18059 Rostock, Germany.
Carita LindholmSTUK - Radiation and Nuclear Safety Authority, Laippatie 4, PO Box 14, 00881 Helsinki, Finland.
Radiation and Nuclear Safety Authority · FIDeutsches Diabetes-Zentrum e.V. · DEUniversity of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In studies reported in the 1960s and since, blood plasma from radiation-exposed individuals has been shown to induce chromosome damage when transferred into lymphocyte cultures of non-irradiated persons. This effect has been described to occur via clastogenic factors, whose nature is still mostly unknown. We have previously examined clastogenic factors from irradiated individuals by looking at plasma-induced DNA damage in reporter cells. Plasma was tested from ca. 30 locally exposed clinical patients receiving fractionated radiation treatment, as well as from three radiological accident victims exposed in 1994, albeit sampled 14 years post-accident. In the current work, proteome changes in the plasma from all subjects were examined with 2D gel electrophoresis-based proteomics techniques, in order to evaluate the level of protein expression with respect to the findings of a clastogenic factor effect. No differences were observed in protein expression due to local radiation exposure (pre- vs post-exposure). In contrast, plasma from the radiation accident victims showed alterations in the expression of 18 protein spots (in comparison with plasma from the control group). Among these, proteins such as haptoglobin, serotransferrin/transferrin, fibrinogen and ubiquitin-60S ribosomal protein L40 were observed, none of them likely to be clastogenic factors. In conclusion, the proteomics techniques applied were unable to identify changes in the proteome of the locally irradiated patients, whereas such differences were observed for the accident victims. However, association with the clastogenic effect or any specific clastogenic factor remains unresolved and thus further studies with more sensitive techniques are warranted.

Indexed as

Radioactive Hazard ReleaseAdultAgedAged, 80 and overBiomarkersBlood ProteinsCase-Control StudiesDNA DamageElectrophoresis, Gel, Two-DimensionalFemaleHumansMaleMiddle AgedMolecular WeightMutagensProteomeBiomarkersBlood ProteinsMutagensProteomeclastogenic factorsionizing radiationlow molecular weight plasma proteinsradiation proteomicstwo-dimensional difference gel electrophoresis (2DE-DIGE)

Identifiers

PMID24570173
PMCPMC4099999
OpenAlexW2131434450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.